Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy
- 31 December 2004
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 191 (6) , 2074-2084
- https://doi.org/10.1016/j.ajog.2004.05.034
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus From Mother to InfantJAMA, 2003
- Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral sheddingEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- HSV-2 specific serology should be offered routinely to antenatal patientsReviews in Medical Virology, 2000
- Prevention of Perinatal Herpes: Prophylactic Antiviral Therapy?Clinical Obstetrics and Gynecology, 1999
- A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infectionBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- The Acquisition of Herpes Simplex Virus during PregnancyNew England Journal of Medicine, 1997
- Neonatal Herpes Simplex Virus Infection in Relation to Asymptomatic Maternal Infection at the Time of LaborNew England Journal of Medicine, 1991
- Acyclovir in late pregnancy to prevent neonatal herpes simplexThe Lancet, 1990
- National Surveillance for Neonatal Herpes Simplex Virus InfectionsSexually Transmitted Diseases, 1989
- Infections with Herpes Simplex VirusesNew England Journal of Medicine, 1986